Everest Medicines Stock Forecast

Buy candidate since Aug 07, 2026 Gain 5.24%

The Everest Medicines Limited stock price gained 0.635% on the last trading day (Tuesday, 11th Aug 2026), rising from HK$28.36 to HK$28.54. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 3.47% from a day low at HK$28.26 to a day high of HK$29.24. The price has risen in 8 of the last 10 days and is up by 14.99% over the past 2 weeks. Volume fell on the last day by -1 million shares and in total, 3 million shares were bought and sold for approximately HK$78.26 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is HK$27.47, a level that may pose a second chance to hit a runner. According to fan-theory HK$34.66 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

1952.HK Signals & Forecast

The Everest Medicines Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at HK$26.46 and HK$26.09. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 16, 2026, and so far it has fallen -1.99%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Everest Medicines Limited stock

On the downside, the stock finds support just below today's level from accumulated volume at HK$25.58 and HK$24.72. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Everest Medicines Limited finds support just below today's level at HK$25.58. If this is broken, then the next support from accumulated volume will be at HK$24.72 and HK$24.66.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved HK$0.98 between high and low, or 3.47%. For the last week, the stock has had daily average volatility of 5.40%.

Our recommended stop-loss: HK$27.62 (-3.22%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 18 days ago.)

Trading Expectations (1952.HK) For The Upcoming Trading Day Of Wednesday 12th

For the upcoming trading day on Wednesday, 12th we expect Everest Medicines Limited to open at HK$28.68, and during the day (based on 14 day Average True Range), to move between HK$27.82 and HK$29.26, which gives a possible trading interval of +/-HK$1.43 (+/-5.16%) up or down from last closing price. If Everest Medicines Limited takes out the full calculated possible swing range there will be an estimated 5.16% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at HK$28.62 (0.28%) than the support at HK$25.58 (10.37%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Everest Medicines Limited stock A Buy?

Several short-term signals are positive and the break-up from the falling trend indicates a possible shift for a trend. We believe that the prices around the breaking point will indicate particularly good levels, but we also believe that the current level will hold a possible good buy level for the short-term period.

Current score: 1.733 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 12, 2026 - HK$28.68 ( 0.491%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk